Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
Filters
Filters
Therapeutic Areas
In Vivo AI Platforms
Mental Illness
Neurodegenerative Disorders
Neurodevelopmental Disorders
Neuromuscular Disorders
Pain
Sleep & Seizure Disorders
Rare CNS Disorders
Traumatic Brain Injury
Specific Disorders
Apply Filters
Filters
PUBLICATION
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.
June 30, 2005
PUBLICATION
Knock-in mouse models of Huntington’s disease.
May 15, 2005
PUBLICATION
Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP.
March 16, 2005
PUBLICATION
Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice.
June 30, 2004
PUBLICATION
Juvenile 5HT(1B) receptor knockout mice exhibit reduced pharmacological sensitivity to 5HT(1A) receptor activation.
May 28, 2004
PUBLICATION
Application of triple-probe microdialysis for fast PK/PD evaluation of dopamimetic activity of drug candidates in the rat brain.
April 26, 2004
PUBLICATION
Striatal plasticity at the network level. Focus on adenosine A(2A) and D(2) interactions in models of Parkinson’s Disease.
March 20, 2004
PUBLICATION
Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats.
January 25, 2004
PUBLICATION
Stress-induced hyperthermia and anxiety: pharmacological validation.
June 30, 2003